<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0047">
 <label>47</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Yuan</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chan</surname>
    <given-names>JFW</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chik</surname>
    <given-names>KKH</given-names>
   </name>, 
   <etal>etÂ al.</etal>
  </person-group>
  <article-title>Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system</article-title>. 
  <source>Pharmacol Res</source>
  <year>2020</year>;
  <volume>159</volume>:
  <fpage>104960</fpage>.
  <pub-id pub-id-type="pmid">32473310</pub-id>
 </mixed-citation>
</ref>
